Archive Newsletter
-
06.26.26 -- Reimagining In Vivo Gene Editing Through Base Editing And Targeted Delivery
6/26/2026
06/26/26 Cell & Gene Newsletter
-
06.25.26 -- Fixing The Fragmentation In Outsourced Pharma
6/25/2026
06/25/26 Cell & Gene Newsletter
-
06.25.26 -- Better Biopharma's Editors' Roundtable — A Midyear Look At The 2026 Life Sciences Industry
6/25/2026
06/25/26
-
06.24.26 -- Smarter risk management for single-use and filtration systems.
6/24/2026
06/24/26 Cell & Gene Newsletter
-
06.24.26 -- What's Driving Cell & Gene Therapy Forward? Key Trends & Insights
6/24/2026
06/24/26 Cell & Gene Newsletter
-
06.24.26 -- Advancing CAR T For Drug-Free Remission In Autoimmune Disease With Kyverna Therapeutics' Dr. Naji Gehchan
6/24/2026
06/24/26 Cell & Gene Newsletter
-
06.23.26 -- STREAM Edition: Why In Vivo Therapies Are Moving Toward The Clinic With Ascidian Therapeutics' Dr. Mike Ehlers
6/23/2026
06/23/26 Cell & Gene Newsletter
-
06.23.26 -- Emerging Technologies In Aseptic Processing: Hype Vs. Operational Reality
6/23/2026
06/23/26 Cell & Gene Newsletter
-
06.22.26 -- Navigating The Next Wave Of AAV Capsid
6/22/2026
06/22/26 Cell & Gene Newsletter
-
06.22.26 -- CDMO Selection: Start With The Relationship, Not The RFP
6/22/2026
06/22/26 Cell & Gene Newsletter